Sichuan Kelun Pharmaceutical Co., Ltd. Class A
002422
Pozycja w akcjach
#2010
Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and... Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. The company operates through Chuanning, Botai, and Other Business segments. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion sets, sterile dispensing and injection syringes, vein detained needles, nebulizer sets, and vacuum blood collection tubes; over-the-counter products; and APIs to treat cardiovascular, IPF, ED, anti-tumor, anti-emetic, antibiotic, VB12, anti-rheumatoid arthritis, multiple sclerosis, anti-schizophrenia, CKD and anti-anemia, polypeptide, and other indications. It also provides ambroxol hydrochloride, potassium chloride, sodium chloride, magnesium sulfate, glucose, sterile water, sodium bicarbonate, lidocaine hydrochloride, vitamin B6, ribavirin, ceftazidime, 5% glucose, and ceftriaxone sodium injections. In addition, the company engages in investment; import and export; enterprise management; logistics and transportation; business services; agricultural non-staple food processing; production and sale of pharmaceutical intermediates; research and development of bio-based materials technology; Internet and related services; crop planting; professional technical; biotechnology extension; socio-economic consultation; technology promotion; medical research and testing exhibition; general cargo road transport; ecological protection and environmental management; and wholesale and retail. It exports its products to Japan. The company was formerly known as Sichuan Kelun Pharmaceutical Factory Co., Ltd and changed its name to Sichuan Kelun Pharmaceutical Co., Ltd. in August 2003. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. operates as a subsidiary of Sichuan Kelun Industry Group CO., LTD.
Cena akcji
$6.40
Kapitalizacja rynkowa
$10.19B
Zmiana (1 dzień)
-0.77%
Zmiana (1 rok)
27.14%
Kraj
CN
Handel Sichuan Kelun Pharmaceutical Co., Ltd. Class A (002422)
Kategoria
Healthcare
Liczba akcji w obrocie dla Sichuan Kelun Pharmaceutical Co., Ltd. Class A (002422)
Liczba akcji w obrocie na dzień June 2026: 1.59B
Zgodnie z najnowszymi raportami finansowymi i ceną akcji Sichuan Kelun Pharmaceutical Co., Ltd. Class A, aktualna liczba akcji w obrocie to 1.59B. Na koniec December 2024 firma posiadała 1.58B akcji w obrocie. Liczba akcji w obrocie jest zwykle kształtowana przez podziały akcji i skupy akcji.
Historia liczby akcji w obrocie dla Sichuan Kelun Pharmaceutical Co., Ltd. Class A (002422) od 2007 do 2026
Akcje w obrocie na koniec każdego roku
| Rok | Akcje w obrocie | Zmień |
|---|---|---|
| 2026 (TTM) | 1.59B | -0.01% |
| 2025 | 1.59B | 0.77% |
| 2024 | 1.58B | 8.61% |
| 2023 | 1.45B | 3.77% |
| 2022 | 1.40B | -0.92% |
| 2021 | 1.41B | -1.15% |
| 2020 | 1.43B | 0.63% |
| 2019 | 1.42B | -0.42% |
| 2018 | 1.43B | -0.30% |
| 2017 | 1.43B | 0.37% |
| 2016 | 1.43B | -0.56% |
| 2015 | 1.43B | 0.18% |
| 2014 | 1.43B | -0.56% |
| 2013 | 1.44B | 0.15% |
| 2012 | 1.44B | -0.33% |
| 2011 | 1.44B | 11.95% |
| 2010 | 1.29B | 19.42% |
| 2009 | 1.08B | 1.52% |
| 2008 | 1.06B | 4.80% |
| 2007 | 1.01B | 0.00% |
Akcje w obrocie dla podobnych firm lub konkurentów
| Firma | Akcje w obrocie | Różnica | Kraj |
|---|---|---|---|
| 253.90M | -84.04% |
US
|
|
| 396.00M | -75.10% |
US
|
|
| 478.91M | -69.89% |
AU
|
|
| 0.00 | -100.00% |
BE
|
|
| 62.19M | -96.09% |
NL
|
